Evidence map›Paper›PMID 36171444›Full record

ArticleScientific reports2022

[

Nika Guberina, Lukas Kessler, Christoph Pöttgen, Maja Guberina, Martin Metzenmacher, Ken Herrmann, Maja Mucha, Christoph Rischpler, Frank Indenkämpen, Jens T Siveke and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Theranostics · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Nika GuberinaDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. nika.guberina@uk-essen.de.
Lukas KesslerDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Christoph PöttgenDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Maja GuberinaDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Martin MetzenmacherDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Maja MuchaDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Christoph RischplerDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Frank IndenkämpenDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Jens T SivekeDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Jürgen TreckmannDepartment of General, Visceral and Transplantation Surgery, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
Lale UmutluInstitute of Diagnostic and Interventional Radiology and Neuroradiology, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
Stefan KasperDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
Wolfgang P FendlerDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
Martin StuschkeDepartment of Radiotherapy, West German Cancer Center (WTZ), University of Duisburg-Essen, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
University of Duisburg-Essen · DEEssen University Hospital · DEDeutschen Konsortium für Translationale Krebsforschung · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biliary-tract-carcinomas (BTC), pancreatic-ductal-adenocarcinomas (PDAC) and adenoidcystic-carcinomas (AC) have in common that they are traditionally treated with large clinical-target-volumes (CTV). The aim of this study is to examine the impact of pretreatment-[

Indexed as

Biliary TractCarcinoma, Adenoid CysticCarcinoma, Pancreatic DuctalPancreatic NeoplasmsFluorodeoxyglucose F18Gallium RadioisotopesHumansPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Gallium Radioisotopes

Identifiers

PMID36171444
PMCPMC9519639
OpenAlexW4297502444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.